| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.007 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |